Alzheimer's disease and Parkinson's disease—Lancet call for papers
Date published:
Wednesday, August 18, 2010News source:
LancetRegion:
International Featured item on home page:
no
Populations are ageing, and the burden of neurodegenerative disease is increasing. By 2030, the global burden of Parkinson's disease is expected to have increased by 25% from 2005 levels, and by 2040 the number of people with dementia worldwide is expected to reach 81·1 million.
Yet effective disease-modifying treatments remain elusive, not only for Alzheimer's and Parkinson's diseases but also for the many other neurodegenerative disorders that, although less common, can be just as devastating for the people affected.
The Lancet Neurology is issuing a call for papers to coincide with the 10th International Conference on Alzheimer's and Parkinson's diseases (AD/PD 2011), which will take place in Barcelona, Spain, March 9—13.
For further information and submission details: Alzheimer's disease and Parkinson's disease—a call for papers
Similar entries
- The ageing brain
- Preventing Alzheimer's disease: could a new kind of trial be the key? Lancet
- Why are drug trials in Alzheimer's disease failing? The Lancet
- Grand Challenges in neurology: a global call for action Lancet
- Alzheimer's disease: a global challenge for the 21st century
- Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: Lancet
- Leading experts in ageing express concern at representations of population ageing: Lancet
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- Continuous Deep Sedation in Medical Practice: A Descriptive Study
